TENM4 and B-cell chronic lymphocytic leukemia: These findings were confirmed in CLL patients with low miR-708-5p expression, as H3K4me1 methylation of enhancer 3 contributed to decreased miR-708-5p levels beyond ODZ4 promoter methylation [33].